Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women

被引:28
作者
Rosado, Eliane Lopes
Bressan, Josefina
Martins, Marta F.
Cecon, Paulo R.
Martinez, Jose Alfredo
机构
[1] Univ Fed Rio de Janeiro, Inst Nutr, Dept Nutr & Dietet, Ilha Fdn, BR-21941590 Rio De Janeiro, Brazil
[2] Univ Fed Vicosa, Dept Nutr, BR-36570000 Vicosa, MG, Brazil
[3] Univ Fed Vicosa, Inst Biotecnol Aplicada Agropecuaria Bioagro, BR-36570000 Vicosa, MG, Brazil
[4] Univ Fed Vicosa, Dept Informat, BR-36570000 Vicosa, MG, Brazil
关键词
obesity; PPARgamnia2; beta2-adrenergie receptor; diet; energy metabolism; eating behavior;
D O I
10.1016/j.appet.2007.04.003
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
In order to evaluate the effect of polymorphism in the PPA Rgamma2 and beta2-adrenergic genes and diet lipids on body composition, energy expenditure and eating behavior of obese women, 60 subjects were submitted to anthropometric, biochemical, dietary, molecular, basal and postprandial metabolism (indirect calorimetry) and eating behavior (visual analog scale) evaluation. Fat and saturated fatty acid (SFA) high diet was used to assess postprandial metabolism. The frequency of Pro12Pro/Gln27Gln, Pro12Pro/Gln27Glu, Pro12Pro/Glu27Glu and Pro12Ala/Gln27Glu genotypes was 35.71%, 30.37%, 23.21% and 10.71%, respectively. These values were not significant (p > 0.05) for the dietary, anthropometric, biochemical and metabolic parameters. The Pro12Ala/Gln27Glu group was found to present greater energy used in postprandial period (EUPP). The presence of the PPARgamma2 gene variant, independent of beta2-adrenergic gene polymorphisin, resulted in fat oxidation increase. Also, this group presented higher satiety, compared to the Pro12Pro/Gln27Gln group. The presence of the variant alleles in the PPARgamma2 gene suggests benefits in food intake control. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:635 / 643
页数:9
相关论文
共 63 条
  • [1] ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771
  • [2] Genetic variance and lipolysis regulation: implications for obesity
    Arner, P
    [J]. ANNALS OF MEDICINE, 2001, 33 (08) : 542 - 546
  • [3] Azcárate TM, 2000, MED CLIN-BARCELONA, V115, P103
  • [4] In situ assessment of the role of the beta(1)-, beta(2)- and beta(3)-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue
    Barbe, P
    Millet, L
    Galitzky, J
    Lafontan, M
    Berlan, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (05) : 907 - 913
  • [5] BEARMER B, 1998, DIABETES, V47, P1806
  • [6] Up-regulation of muscle UCP2 gene expression by a new β3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animals
    Berraondo, B
    Marti, A
    Duncan, JS
    Trayhurn, P
    Martínez, JA
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (02) : 156 - 163
  • [7] BLUNDELL JE, 1993, AM J CLIN NUTR, V57, P772
  • [8] BODEN G, 1993, J CLIN INVEST, V100, P1107
  • [9] THE RELATION BETWEEN INSULIN SENSITIVITY AND THE FATTY-ACID COMPOSITION OF SKELETAL-MUSCLE PHOSPHOLIPIDS
    BORKMAN, M
    STORLIEN, LH
    PAN, DA
    JENKINS, AB
    CHISHOLM, DJ
    CAMPBELL, LV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (04) : 238 - 244
  • [10] BRAY GA, 1988, WESTERN J MED, V149, P429